Miricorilant
CORT118335-856
Phase 1 small_molecule completed
Quick answer
Miricorilant for Antipsychotic Induced Weight Gain is a Phase 1 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Antipsychotic Induced Weight Gain
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed